SPR Therapeutics’ Pain Management Device Gains Clearance

August 4, 2016

SPR Therapeutics has received clearance from the FDA to market the Sprint Peripheral Nerve Stimulation (PNS) system.

The pain management device allows lead placement two to three centimeters from the intended nerve.

The PNS is fully reversible, as the device is designed to be removed without surgery at the end of the 30-day treatment period. — Tamra Sami

View today's stories